Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
2.605
-0.005 (-0.19%)
Sep 18, 2024, 4:00 PM EDT - Market closed
Immuron Market Cap
Immuron has a market cap or net worth of $14.96 million as of September 18, 2024. Its market cap has increased by 41.17% in one year.
Market Cap
14.96M
Enterprise Value
7.19M
1-Year Change
41.17%
Ranking
Category
Stock Price
$2.61
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $14.96M, a decrease of -46.75%. That is a compound annual growth rate of -8.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2024 | 15.00M | 40.19% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunoPrecise Antibodies | 15.46M |
| Flora Growth | 15.43M |
| BriaCell Therapeutics | 15.35M |
| Turnstone Biologics | 15.30M |
| Cutera | 15.28M |
| Evogene | 15.18M |
| Aytu BioPharma | 15.17M |
| Galecto | 15.03M |